City of Hopes cancer-killing pill works like a snowstorm shutting ... - FierceBiotech

MYMDDelisted Stock  USD 1.82  0.02  1.09%   
About 62% of MYMD Old's investor base is looking to short. The analysis of current outlook of investing in MYMD Old suggests that many traders are alarmed regarding MYMD Old's prospects. The current market sentiment, together with MYMD Old's historical and current headlines, can help investors time the market. In addition, many technical investors use MYMD Old stock news signals to limit their universe of possible portfolio assets.
  
City of Hopes cancer-killing pill works like a snowstorm shutting ... FierceBiotech

Read at news.google.com
Google News at Macroaxis
  

MYMD Old Fundamental Analysis

We analyze MYMD Old's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MYMD Old using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MYMD Old based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

EBITDA

EBITDA Comparative Analysis

MYMD Old is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

MYMD Old Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MYMD Old stock to make a market-neutral strategy. Peer analysis of MYMD Old could also be used in its relative valuation, which is a method of valuing MYMD Old by comparing valuation metrics with similar companies.

Peers

MYMD Old Related Equities

UBXUnity Biotechnology   34.59   
0%
100.0%
NBYNovaBay Pharmaceuticals   9.37   
0%
27.0%
PASGPassage Bio   1.52   
0%
4.0%
GOVXGeoVax Labs   1.36   
0%
3.0%
KZRKezar Life   1.06   
3.0%
0%
AVIRAtea Pharmaceuticals   2.10   
6.0%
0%
KROSKeros Therapeutics   2.22   
6.0%
0%
KRONKronos Bio   3.03   
8.0%
0%
LRMRLarimar Therapeutics   3.43   
9.0%
0%
LGNDLigand Pharmaceuticals   3.89   
11.0%
0%
REPLReplimune   4.08   
11.0%
0%
RXRXRecursion Pharmaceuticals   5.23   
15.0%
0%
BOLTBolt Biotherapeutics   5.26   
15.0%
0%
XBIOXenetic Biosciences   5.39   
15.0%
0%
NVCTNuvectis Pharma   5.83   
16.0%
0%
ORICOric Pharmaceuticals   6.35   
18.0%
0%
GOSSGossamer Bio   7.62   
22.0%
0%
LYELLyell Immunopharma   7.69   
22.0%
0%
REVBRevelation Biosciences   8.62   
24.0%
0%
LYRALyra Therapeutics   9.09   
26.0%
0%
DSGNDesign Therapeutics   11.02   
31.0%
0%
SRZNSurrozen   12.96   
37.0%
0%
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Consideration for investing in MYMD Stock

If you are still planning to invest in MYMD Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MYMD Old's history and understand the potential risks before investing.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Stocks Directory
Find actively traded stocks across global markets
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals